Transglutaminase 2 Stimulates Cell Proliferation and Modulates Transforming Growth Factor-Beta Signaling Pathway Independently of Epithelial–Mesenchymal Transition in Hepatocellular Carcinoma Cells
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26125497 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Hiromi Yamaguchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, Tokyo 173-8610, Japan. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Transglutaminases, Carcinoma, Hepatocellular, GTP-Binding Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Transglutaminase 2 (TG2) is a multifunctional protein and plays a role in cancer progression. We previously identified TG2 as an early-recurrence biomarker in hepatocellular carcinoma (HCC). TG2-knockdown (shTG2) and control (shCtl) HCC cell lines were used for comparative analyses to clarify the molecular mechanisms underlying the contribution of this protein to HCC malignancy. The proliferation of shTG2 cells was slightly but significantly decreased compared with that of shCtl cells. Differential gene expression profiling based on GeneChip arrays revealed the enrichment of the PI3K-Akt signaling pathway and showed that the expression of Dickkopf-1 and -3 (DKK1 and DKK3, respectively), inhibitors and modulators of the Wnt/β-catenin signaling pathway, was increased in shTG2 cells. The expression of epithelial–mesenchymal transition (EMT)-related genes was similar in both shCtl and shTG2 cells before and after TGF-β1 treatment, even though TGF-β1 markedly upregulated TG2. Thus, TG2 may contribute to cancer malignancy via the stimulation of cell proliferation signaling, such as PI3K-Akt and Wnt/β-catenin signaling, but not EMT. This effect might be further enhanced by humoral factors such as TGF-β1 from the tumor microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, Tokyo 173-8610, Japan.
- Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.
ORCID-Profile: Ramiro José González-Duarte, Xian-Yang Qin, Verna Cázares-Ordoñez, Makoto Makishima, Mariko Esumi
Förderung
- JSPS KAKENHI
Zitieren
APA
Yamaguchi, H., González-Duarte, R. J., Qin, X. Y., Abe, Y., Takada, I., Charroy, B., Cázares-Ordoñez, V., Uno, S., Makishima, M., & Esumi, M. (2025). Transglutaminase 2 Stimulates Cell Proliferation and Modulates Transforming Growth Factor-Beta Signaling Pathway Independently of Epithelial–Mesenchymal Transition in Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125497
Vancouver
Yamaguchi H, González-Duarte RJ, Qin XY, Abe Y, Takada I, Charroy B, et al. Transglutaminase 2 Stimulates Cell Proliferation and Modulates Transforming Growth Factor-Beta Signaling Pathway Independently of Epithelial–Mesenchymal Transition in Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125497
BibTeX
@article{Yamaguchi2025,
author = {Yamaguchi, Hiromi and González-Duarte, Ramiro José and Qin, Xian-Yang and Abe, Yuriko and Takada, Ichiro and Charroy, Benjamin and Cázares-Ordoñez, Verna and Uno, Shigeyuki and Makishima, Makoto and Esumi, Mariko},
title = {Transglutaminase 2 Stimulates Cell Proliferation and Modulates Transforming Growth Factor-Beta Signaling Pathway Independently of Epithelial–Mesenchymal Transition in Hepatocellular Carcinoma Cells},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26125497}
}
EUVIMED